
N,N,N',N',N'',N''-Hexamethoxymethylmelamine | CAS:3089-11-0
N,N,N',N',N'',N''-Hexamethoxymethylmelamine
- 名称:N,N,N',N',N'',N''-六甲氧基甲基三聚氰胺 | N,N,N',N',N'',N''-Hexamethoxymethylmelamine
- CAS号:3089-11-0
- 别名:Hexamethyl methylolmelamine; Hexamethylolmelamine hexamethyl ether; N,N,N',N',N'',N''-Hexakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine
- 分子式:C15H30N6O6
- 分子量:390.44
- EINESC号:221-422-3
产品描述
物理化学性质
熔点 | 49 ºC** |
---|---|
密度 | 1.219±0.06 g/cm3 (20 º |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation.Mike Frohn et al.Bioorganic & medicinal chemistry letters, 17(23), 6633-6637 (2007-10-09)
Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.Eduard Badarau et al.Bioorganic & medicinal chemistry letters, 19(6), 1600-1603 (2009-02-25)
Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.Ronald Palin et al.Bioorganic & medicinal chemistry letters, 15(3), 589-593 (2005-01-25)
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.Anna-Maria Monforte et al.Bioorganic & medicinal chemistry, 17(16), 5962-5967 (2009-07-21)
The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives.Hirofumi Omura et al.Bioorganic & medicinal chemistry letters, 18(11), 3310-3314 (2008-04-29)
Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones.P Zhang et al.Bioorganic & medicinal chemistry letters, 11(20), 2747-2750 (2001-10-10)
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors.Milan Bruncko et al.Bioorganic & medicinal chemistry letters, 20(24), 7503-7506 (2010-11-26)
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase.Kim F McClure et al.Journal of medicinal chemistry, 48(18), 5728-5737 (2005-09-02)
Multiple tandem mass spectrometry-based investigation of the behaviour of some thiazol-benzimidazolones and 2-benzimidazolylsulfanyl ethanones.Susanna Vogliardi et al.European journal of mass spectrometry (Chichester, England), 11(1), 43-51 (2005-06-11)
Quantitative gas chromatographic analysis of [1-(4-piperidinyl)-1,3-dihydro-2H-benzimidazole-2-one], the basic metabolite of bezitramide (Burgodin), in human urine.S M De Baere et al.Journal of analytical toxicology, 22(1), 18-26 (1998-03-10)
Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region.Ho Yin Lo et al.Bioorganic & medicinal chemistry letters, 21(15), 4533-4539 (2011-07-08)
Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.S M Candura et al.British journal of pharmacology, 118(8), 1965-1970 (1996-08-01)
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity.Jana A Lewis et al.Bioorganic & medicinal chemistry letters, 19(7), 1916-1920 (2009-03-10)
Design, synthesis and structure-activity relationship of novel tricyclic benzimidazolone derivatives as potent 18 kDa translocator protein (TSPO) ligands.Takayuki Fukaya et al.Bioorganic & medicinal chemistry, 21(5), 1257-1267 (2013-01-29)
Rapid liquid-phase combinatorial synthesis of heterocyclic libraries.Chung-Ming Sun Methods in molecular biology (Clifton, N.J.), 201, 141-166 (2002-10-03)
Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures.Ahmed Kamal et al.Mini reviews in medicinal chemistry, 6(1), 71-89 (2006-02-07)
Structures of six industrial benzimidazolone pigments from laboratory powder diffraction data.Jacco van de Streek et al.Acta crystallographica. Section B, Structural science, 65(Pt 2), 200-211 (2009-03-21)
Towards the synthesis of new benzimidazolone derivatives with surfactant properties.Brahim Lakhrissi et al.Carbohydrate research, 343(3), 421-433 (2007-12-25)
Natural modulators of large-conductance calcium-activated potassium channels.Antonio Nardi et al.Planta medica, 69(10), 885-892 (2003-12-04)
Potent benzimidazolone based human beta(3)-adrenergic receptor agonists.Don R Finley et al.Bioorganic & medicinal chemistry letters, 16(21), 5691-5694 (2006-08-26)
Structural elucidation of rabeprazole sodium photodegradation products.Cássia V Garcia et al.Journal of pharmaceutical and biomedical analysis, 46(1), 88-93 (2007-10-20)
Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activity.Qun Li et al.Bioorganic & medicinal chemistry letters, 15(11), 2918-2922 (2005-05-25)
Potent benzimidazolone-based CGRP receptor antagonists.Cory R Theberge et al.Bioorganic & medicinal chemistry letters, 18(23), 6122-6125 (2008-10-25)
Effect of nitro groups on the photo physical properties of benzimidazolone: a solvatochromic study.V Madhura et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 84(1), 137-143 (2011-10-05)
Liquid phase synthesis of arylamines and its application to the benzimidazolone via nucleophilic aryl substitution.P C Pan et al.Bioorganic & medicinal chemistry letters, 9(11), 1537-1540 (1999-07-01)
CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds.Emanuela Caci et al.American journal of physiology. Lung cellular and molecular physiology, 285(1), L180-L188 (2003-03-26)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!